Alex is currently the Senior Vice President of Market Access at Nektar Therapeutics where he is responsible for ensuring commercial readiness for their first commercial product launch. In this role Alex is responsible for Payer Marketing, Channel Management, Pricing, Contracting, Patient Services, Account Management, and Reimbursement Support. Prior to joining Nektar in October, 2020 he was at Lexicon Pharmaceuticals for 5.5 years where he held the position EVP, Chief Commercial Officer responsible for leading all aspects of the commercial organization to include Sales, Marketing, Market Access, and Business Analytics. Before joining Lexicon Pharmaceuticals in 2015, Alex was at Bayer Healthcare where he held the position of EVP, US Market Access responsible for Payer Marketing, Pricing & Contracting, Channel Management , Account Management , and Patient Services. In this role, as an US Executive Committee member he also represented US Market Access function on the Global Leadership Committee, a committee comprised of 250 senior executives worldwide. Innovative and results driven healthcare executive focused on achieving exceptional results in highly competitive environments that demand continuous improvement. With over 30 years of varied health care experience Alex has demonstrated ability to build, lead, and motivate cross functional teams that exceed corporate expectations. Experienced in driving successful product launches and customer service improvements while building strategic partnerships with key decision makers both externally and internally within an organization. Successfully launched numerous brands in diverse specialty therapeutic categories with all brands meeting and/or exceeding all market launch objectives.